CBB Workshop: UWaterloo Intellectual Property Part 2 Case Study

Wednesday, September 21, 2016 10:30 am - 12:00 pm EDT (GMT -04:00)

Presented by:
Eric Luvisotto, Technology Transfer Officer, University of Waterloo, Waterloo Commercialization Office 

The Waterloo Commercialization Office (WatCo) offers commercialization services and expertise to package and convert research innovations into commercially viable products and services.

The workshop will start with a quick overview of the types of intellectual property protection covered in a previous presentation, and the majority of the workshop focused on a real-life case study.  A Q&A and short networking session will follow.

Agenda:
10:15 - Sign-in
10:30 - Introduction and review of UWaterloo IP
10:40 - Case Study that touches on all the main types of IP
11:30 - Q&A, networking
12:00 - Close

Biosketch:
Eric is a registered Canadian Patent Agent (2003) and has earned his Master’s and Bachelor’s degrees in Engineering from the University of Waterloo.  He is a member of the Intellectual Property Institute of Canada (IPIC), and the Licensing Executives Society with the Association of University Technology Managers (AUTM).

Eric has many years of experience in the field of Intellectual Property (IP) and spans a wide variety of experiences including working for two Canadian IP law firms, founding and running his own Start-Up company, and working “in-house” for a large automotive parts manufacturer.

As a Technology Transfer Officer with the Waterloo Commercialization Office (WatCo) at the University of Waterloo since 2008, Eric analyzes new ideas for patentability and commercial potential, negotiates licensing agreements, and is also involved with the facilitation of Start-Up companies.

Eric is a popular guest lecturer on Intellectual Property and UW’s IP Policy.  He regularly presents an “IP 101” and “IP Case Study” for faculty, students and other groups at the University of Waterloo.

Registration is required 

Pay parking available in lots Q or N 

The workshop is supported by the Centre for Bioengineering and Biotechnology (CBB)